tipe 1 diabetes melitus induction (streptozicin based.pptx

Post on 14-Apr-2018

224 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 1/16

Type 1 Diabetes Melitus

Induction (streptozocin based)

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 2/16

Diabetes

• Diabetes is a chronic disease, which occurs

when the pancreas does not produce

enough insulin, or when the body cannot 

effectively use the insulin it produces. This

leads to an increased concentration of 

glucose in the blood (hyperglycaemia)

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 3/16

Diabetes

Diabetes

Type 1

diabetes

Type 2

diabetes

Gestational

diabetes

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 4/16

Diabetes mellitus Type 1

• Type 1 diabetes (previously known as

insulin-dependent or childhood-onset 

diabetes) is characterized by a lack of 

insulin production.

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 5/16

ANIMAL MODEL OF DIABETES(STREPTOZOCIN BASED)

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 6/16

Streptozocin (STZ)

• Isolated from Streptomyces achromogenes

• Its diabetogenic properties characterized by selective destruction

of pancreatic islet β-cells mimic human type 1 diabetes mellitus

• Several species, including the mouse, rat, rabbit, and monkey, are

sensitive to the pancreatic β-cell cytotoxic effects of STZ

C8H15N3O7

Mol. Weight : 265,22 g/mol

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 7/16

STZ

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 8/16

Animal

STZ

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 9/16

Inducing Diabetes

• Basic Protocol 1 (mice)• multiple administrations of low-dose STZ to

produce diabetic mice

• close resemblance to human T1DM with chronicpancreatic islet inflammation, insulitis, and insulin

deficiency 

• The cost effectiveness related to the small size of the

animal

• Basic Protocol 2 (rat)

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 10/16

Inducing Diabetes

• Basic Protocol 1 (mice)

• Basic Protocol 2 (rat)• Not used as commonly as the mouse model

• Using a single, high dose Streptozocin

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 11/16

BASIC PROTOCOL 1

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 12/16

Material

• C57BL/6 or CD-1 male mice: ∼ 25 g, 8 to 12 weeksold

• 50 mM sodium citrate buffer, pH 4.5

Streptozotocin• 10% (w/v) sucrose

• 1.5-ml microcentrifuge tubes

• Aluminum foil

• 1-ml syringes• 25-G needles

• One Touch Basic blood glucose monitoring system

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 13/16

Animal Preparation

4 dayprior

remove

food

Day 1

Treat withSTZ

2-5consecutiveday

Repeattreating

with STZ

Day 6Switch

sucrose to

regular

water

Day 14

Test bloodglucose

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 14/16

Streptozocin Treatment Preparation

• Prepare 50 mM sodium citrate buffer, place

1ml into 1.5-ml microcentrifuge tube. Cover

tube with aluminium foil

• Dissolve STZ in the 50mM sodium citrate to

final conc. 6 mg/ml

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 15/16

Streptozocin Treatment 

• Inject STZ sol. IP at 40 mg/kg

• Return mice to their cage. Provide normal

food and 10% sucrose water

• Repeat treatment for next 4 consecutive day

• On day 6, switch the 10% sucrose with

regular water

7/27/2019 Tipe 1 Diabetes Melitus Induction (streptozicin based.pptx

http://slidepdf.com/reader/full/tipe-1-diabetes-melitus-induction-streptozicin-basedpptx 16/16

Diabetic State

• On experimental day 14 (9 days after STZ

injection) fast mice for 6 hr. test the blood

glucose

• Fasting glucose >150 mg/dl

• For retest of group failing of the first test,

test the blood glucose on day 28

• Severe diabetes develop 3 wk after injection

top related